ESPR FY 2000 Earnings — Esperion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ESPREsperion Therapeutics, Inc.

$481M

FY 2000 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2,000

Gross Profit

-$784,000-39200.0% margin

Operating Income

-$28M-1378600.0% margin

Net Income

-$28M-1378800.0% margin

EPS (Diluted)

$-9.35

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$78M

Total Liabilities

$10M

Stockholders' Equity

$68M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2,000	$0	—
Gross Profit	-$784,000	-$683,223	-14.8%
Operating Income	-$28M	-$12M	-122.9%
Net Income	-$28M	-$11M	-158.4%